Your browser doesn't support javascript.
loading
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis.
Njouendou, Abdel Jelil; Szarvas, Tibor; Tiofack, Arnol Auvaker Zebaze; Kenfack, Rovaldo Nguims; Tonouo, Pamela Derliche; Ananga, Sidonie Noa; Bell, Esther H M Dina; Simo, Gustave; Hoheisel, Jörg D; Siveke, Jens T; Lueong, Smiths S.
Afiliação
  • Njouendou AJ; Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, Buea, South West Region, Cameroon.
  • Szarvas T; Phytopharmacy and Drug Discovery Section, The Cameroon Consortium for Translational Cancer Research (CCOTCARE), Douala, Cameroon.
  • Tiofack AAZ; Department of Urology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, 45122, Essen, Germany.
  • Kenfack RN; Department of Urology, Semmelweis University, 1082, Budapest, Hungary.
  • Tonouo PD; Molecular Parasitology and Entomology Unit (MPEU), Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, West Region, Cameroon.
  • Ananga SN; Early Detection and Biomarker Section, The Cameroon Consortium for Translational Cancer Research (CCOTCARE), Douala, Cameroon.
  • Bell EHMD; Early Detection and Biomarker Section, The Cameroon Consortium for Translational Cancer Research (CCOTCARE), Douala, Cameroon.
  • Simo G; Research Unit of Microbiology and Antimicrobial Substances (RUMAS), Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, West Region, Cameroon.
  • Hoheisel JD; Early Detection and Biomarker Section, The Cameroon Consortium for Translational Cancer Research (CCOTCARE), Douala, Cameroon.
  • Siveke JT; Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Littoral Region, Cameroon.
  • Lueong SS; Department of Medical Oncology, Douala General Hospital, Douala, Littoral Region, Cameroon.
Mol Cancer ; 22(1): 52, 2023 03 17.
Article em En | MEDLINE | ID: mdl-36932385

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article